Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIVOCERANIB for Hepatocellular carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where RIVOCERANIB was used for Hepatocellular carcinoma.

Most Reported Side Effects for RIVOCERANIB

Side Effect Reports % Deaths Hosp.
Myelosuppression 28 40.6% 2 17
Thrombocytopenia 13 18.8% 1 3
Nausea 11 15.9% 1 3
Off label use 10 14.5% 1 3
Anaemia 9 13.0% 1 1
Hypertension 9 13.0% 0 0
Neutropenia 9 13.0% 0 1
Leukopenia 8 11.6% 0 1
Vomiting 8 11.6% 1 2
Diarrhoea 7 10.1% 0 1
Hypothyroidism 7 10.1% 0 0
Pneumonia 7 10.1% 3 4
Rash 6 8.7% 0 0
Decreased appetite 5 7.3% 0 2
Fatigue 5 7.3% 0 1

Other Indications for RIVOCERANIB

Gastric cancer (14) Hepatic cancer (7)

Other Drugs Used for Hepatocellular carcinoma

ATEZOLIZUMAB (8,443) BEVACIZUMAB (7,773) LENVATINIB (5,384) SORAFENIB (4,986) CABOZANTINIB S-MALATE (2,670) DURVALUMAB (1,255) NIVOLUMAB (1,142) REGORAFENIB (1,050) TREMELIMUMAB\TREMELIMUMAB-ACTL (589) PEMBROLIZUMAB (518)

Related Pages

RIVOCERANIB Full Profile All Hepatocellular carcinoma Drugs RIVOCERANIB Demographics RIVOCERANIB Timeline